Skip to main content
OpenTrials
Completed

NCT Number: NCT02868944

Interest of the Injection of Morphine, in Addition to a Local Anesthetic When Performing a Combined Spinal-epidural for Labor Analgesia

The addition of morphine to a local anesthetic when performing an epidural analgesia during labor analgesia has improved the efficiency and the action duration of analgesia. One limitation of this technique is the time of installation of the analgesic effect (about 30 minutes) when using the only epidural. Therefore, the technique of sequential combined spinal epidural was introduced. This is to shorten the installation time by direct injection into the cerebrospinal fluid. This allows a good efficiency in less than 10 minutes. It has been shown that low doses of sufentanil (strong opioid) in spinal anesthesia could potentiate the effect of the local anesthetic.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Chu de Reims

Reims, 51092, France

About this study

Compare the results of obstetric analgesia by sequential combined spinal epidural with local anesthetic injection associated with morphine and a sequential obstetric analgesia by sequential combined spinal epidural with local anesthetic injection alone

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pregnant patients
  • patients who experienced a physiological course of pregnancy
  • patients for which it was estimated eutrophic fetus without pathology found during ultrasound
  • patient consenting to participate to the study
  • patient enrolled in the national healthcare insurance program
  • patient older than 18 years and younger than 40 years

Exclusion criteria

  • twin pregnancy
  • contraindication to sequential combined spinal epidural

Treatment and study plan

experimental group : sequential combined spinal epidural with local anesthetic injection (chirocaine) associated with morphine (sufentanil).

Drug

control group : sequential combined spinal epidural with local anesthetic injection (chirocaine) alone.

Drug

Primary outcomes

  1. Visual analog pain scale

    Time frame: after 5 minutes

    Pain evaluated inferior at 3 on 10 using a visual analog pain scale

Sponsors and collaborators

Lead sponsor

CHU de Reims

Other

Registry information

Acronym: MASEA

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Aug 16, 2016
Registry last updated
Jan 9, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.